相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis
Lavinia Palamiuc et al.
EMBO MOLECULAR MEDICINE (2015)
Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis
Yu-Ju Liu et al.
FEBS LETTERS (2015)
Preconditioning with latrepirdine, an adenosine 5′-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1G93A mice
Karen S. Coughlan et al.
NEUROBIOLOGY OF AGING (2015)
Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis
Yu-Ju Liu et al.
HUMAN MOLECULAR GENETICS (2015)
Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis
G. Yacila et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis
Maria A. Lim et al.
HUMAN MOLECULAR GENETICS (2014)
Adenosine monophosphate-activated protein kinase activation enhances embryonic neural stem cell apoptosis in a mouse model of amyotrophic lateral sclerosis
Yanling Sui et al.
NEURAL REGENERATION RESEARCH (2014)
Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models
Nirma D. Perera et al.
PLOS ONE (2014)
Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model
Csilla Ari et al.
PLOS ONE (2014)
Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration
A. T. Behan et al.
CELL DEATH AND DIFFERENTIATION (2013)
PGC-1 is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
Judith Eschbach et al.
HUMAN MOLECULAR GENETICS (2013)
The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons
Wenzhang Wang et al.
HUMAN MOLECULAR GENETICS (2013)
Why does brain metabolism not favor burning of fatty acids to provide energy? - Reflections on disadvantages of the use of free fatty acids as fuel for brain
Peter Schoenfeld et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis
Pablo M. Peixoto et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2013)
The changing scene of amyotrophic lateral sclerosis
Wim Robberecht et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis
Eva Lindauer et al.
PLOS ONE (2013)
Systemic Down-Regulation of Delta-9 Desaturase Promotes Muscle Oxidative Metabolism and Accelerates Muscle Function Recovery following Nerve Injury
Ghulam Hussain et al.
PLOS ONE (2013)
TDP-43, an ALS Linked Protein, Regulates Fat Deposition and Glucose Homeostasis
Nancy R. Stallings et al.
PLOS ONE (2013)
Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis
James C. Dodge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Premorbid body mass index and risk of amyotrophic lateral sclerosis
Eilis J. O'Reilly et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Reducing systemic hypermetabolism by inducing hypothyroidism does not prolong survival in the SOD1-G93A mouse
Jia Li et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
Elevated PGC-1α Activity Sustains Mitochondrial Biogenesis and Muscle Function without Extending Survival in a Mouse Model of Inherited ALS
Sandrine Da Cruz et al.
CELL METABOLISM (2012)
The Critical Role of Metabolic Pathways in Aging
Nir Barzilai et al.
DIABETES (2012)
Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats
Cao Huang et al.
HUMAN MOLECULAR GENETICS (2012)
Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice
Kazunori Miyazaki et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Sweet sixteen for ANLS
Luc Pellerin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Malonyl-CoA: the regulator of fatty acid synthesis and oxidation
Daniel W. Foster
JOURNAL OF CLINICAL INVESTIGATION (2012)
Reduced Activity of AMP-Activated Protein Kinase Protects against Genetic Models of Motor Neuron Disease
M. A. Lim et al.
JOURNAL OF NEUROSCIENCE (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS
Arunabh Bhattacharya et al.
NEUROBIOLOGY OF AGING (2012)
Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease
Wei Zhao et al.
PLOS ONE (2012)
Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation
Mireille Belanger et al.
CELL METABOLISM (2011)
Cold pre-conditioning neuroprotection depends on TNF-α and is enhanced by blockade of interleukin-11
Heidi M. Mitchell et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis
J. Dorst et al.
JOURNAL OF NEUROLOGY (2011)
Energy metabolism in amyotrophic lateral sclerosis
Luc Dupuis et al.
LANCET NEUROLOGY (2011)
Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis
Wei Zhao et al.
MOLECULAR NEURODEGENERATION (2011)
PGC-1α PROTECTS NEURONS AND ALTERS DISEASE PROGRESSION IN AN AMYOTROPHIC LATERAL SCLEROSIS MOUSE MODEL
Huiyun Liang et al.
MUSCLE & NERVE (2011)
Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1G93A Mouse Model of ALS and Is Harmful in Female Mice
Hannah M. Kaneb et al.
PLOS ONE (2011)
A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS
Ali Jawaid et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice
Daniel J. Amante et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Impaired glucose tolerance in patients with amyotrophic lateral sclerosis
Pierre-Francois Pradat et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Extensive FUS-Immunoreactive Pathology in Juvenile Amyotrophic Lateral Sclerosis with Basophilic Inclusions
Eric J. Huang et al.
BRAIN PATHOLOGY (2010)
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus
A. Jawaid et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Effects of AMP-activated protein kinase in cerebral ischemia
Jun Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice
Ya-Fei Xu et al.
JOURNAL OF NEUROSCIENCE (2010)
Caloric Restriction Shortens Lifespan through an Increase in Lipid Peroxidation, Inflammation and Apoptosis in the G93A Mouse, an Animal Model of ALS
Barkha P. Patel et al.
PLOS ONE (2010)
Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism
Po-Min Chiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice
Xiu Shan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structure and function of AMP-activated protein kinase
J. S. Oakhill et al.
ACTA PHYSIOLOGICA (2009)
Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy
Jeroen Poels et al.
BIOESSAYS (2009)
Blood lactate is an important energy source for the human brain
Gerrit van Hall et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
AMPK in the brain: its roles in energy balance and neuroprotection
Gabriele V. Ronnett et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Hypermetabolism in ALS patients: an early and persistent phenomenon
C. Bouteloup et al.
JOURNAL OF NEUROLOGY (2009)
Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?
Nachum Vaisman et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons
Luc Dupuis et al.
PLOS ONE (2009)
Are statin medications safe in patients with ALS?
Lorne Zinman et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
L. Dupuis et al.
NEUROLOGY (2008)
An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system
Eric Colman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Sports and trauma in amyotrophic lateral sclerosis revisited
Carmel Armon
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis
Ennio Esposito et al.
BRAIN RESEARCH (2007)
Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis
Anissa Fergani et al.
JOURNAL OF LIPID RESEARCH (2007)
A randomized controlled trial of resistance exercise in individuals with ALS
V. Dal Bello-Haas et al.
NEUROLOGY (2007)
Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model
Jong-Ha Park et al.
NEUROSCIENCE LETTERS (2007)
Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-sod mutant G93A mice
Mazien J. Hamadeh et al.
MUSCLE & NERVE (2006)
Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS
Susan E. Browne et al.
NEUROBIOLOGY OF DISEASE (2006)
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhong Zhao et al.
BMC NEUROSCIENCE (2006)
Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: A temporal study in man
A Echaniz-Laguna et al.
EXPERIMENTAL NEUROLOGY (2006)
Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice
M Damiano et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-L-propylamino-benzathiazole dihydrochloride]
R Danzeisen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice
JLG de Aguilar et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
A Chiò et al.
BRAIN (2005)
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters
Jean-Claude Desport et al.
NEURODEGENERATIVE DISEASES (2005)
Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse
MJ Hamadeh et al.
MUSCLE & NERVE (2005)
Physical activity and the association with sporadic ALS
JH Veldink et al.
NEUROLOGY (2005)
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis:: benefit of a high-energy diet in a transgenic mouse
L Dupuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lactate is a preferential oxidative energy substrate over glucose for neurons in culture
AK Bouzier-Sore et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Lactate:: A preferred fuel for human brain metabolism in vivo
D Smith et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis
CW Jung et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Premorbid weight, body mass, and varsity athletics in ALS
N Scarmeas et al.
NEUROLOGY (2002)
Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice
M Mattiazzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
APOE: A potential marker of disease progression in ALS
L Lacomblez et al.
NEUROLOGY (2002)
Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice
N Leclerc et al.
NEUROMUSCULAR DISORDERS (2001)
Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity
C Bendotti et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
The value of muscle exercise in patients with amyotrophic lateral sclerosis
VE Drory et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
分享论文
